GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human PI3K-gamma in complex with pyridinylquinoline inhibitor N-{(1S)-1-[8-chloro-2-(2-methylpyridin- 3-YL)QUINOLIN-3-YL]ETHYL}-9H-purin-6-amine

Analyse Crystal structure of human PI3K-gamma in complex with pyridinylquinoline… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4WWP
Type
protein
Length
820 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P48736
Ligands
3VE, SO4
Pockets
12 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153, 2.7.11.1)protein82046% helix, 18% strandP48736

Ligands and binding sites

  • 3VE · N-{(1S)-1-[8-chloro-2-(2-methylpyridin-3-yl)quinolin-3-yl]ethyl}-9H-purin-6-amine · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111550.810.8380SO4, GOL
22880.680.8340empty
3500.660.9619empty
43470.650.79363VE
52050.560.7933empty

Compared structures

  • 4WWP · Crystal structure of human PI3K-gamma in complex with pyridinylquinoline inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.